Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Archer Aviation

Standard Lithium Ltd

Before investing in equities, there needs to be a clearly defined objective. Some investors prefer blue-chip dividend stocks for regular cash inflows, while others seek multibagger growth stories that can help in multiplying an initial investment.

3 Stocks Under $10 for 10-Bagger Returns by 2030

TORONTO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 fourth quarter and full-year earnings conference call on Thursday, February 29, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024

Canopy Growth

SNDL Inc.

The Canadian cannabis sector remains a hotbed of activity, drawing attention from investors globally. With legalization trends expanding, Canadian marijuana stocks are at the forefront. This week, several companies stand out due to their market movements and potential growth opportunities. Investors are keenly watching these stocks. They're looking for signs of strong financial health and strategic positioning. Overall, the global cannabis industry's expansion plays a crucial role in this interest.

Cannabis Market Movers: Canada's Top Picks for Mid-February 2024

Cronos Group has a cash position of $840 million, which is over 100% of its market cap, and zero debt. The company is trading at a discount to book value, with a potential 36% upside if the stock trades in line with book value. Cronos Group's operational losses are a factor in the current discount, but the company has seen improvements in revenue and gross profit.

Cronos Group: Flush With Cash And Trading Below Book Value

Curaleaf Holdings, Inc.

Tilray Brands

Newly released documents indicate that the U.S. Food and Drug Administration (FDA) has “determined that cannabis has a legitimate medical use and that it should be moved from Schedule I to Schedule III on the controlled substances list.” With Presidential elections round the corner, there are hopes for federal level legalization of cannabis.

3 Cannabis Stocks to Buy for the Next Bull Run: February 2024

The Canadian cannabis industry and top marijuana stocks witnessing a dynamic shift. This week, top Canadian cannabis stocks are in the spotlight. The market's interest is heightened due to evolving regulations and growing global demand. Canadian players are uniquely positioned. They leverage advanced cultivation techniques and expansive distribution networks. These strengths give them a competitive edge in the global cannabis market. The industry's evolution is closely watched by investors. They seek to capitalize on these emerging opportunities.

Top Canadian Cannabis Stocks to Watch Before February 2024

Aurora Cannabis

GrowGeneration Corp

OrganiGram Holdings Inc.

Given recent news items regarding the federal legalization of cannabis, you may think now is the time to be thinking about which cannabis stocks to buy, not which cannabis stocks to sell. Yes, the release of a letter from the U.S. Department of Health and Human Services, recommending that marijuana be rescheduled as a Schedule III drug, may be seen as signs of marijuana legalization progress.

7 Cannabis Stocks to Sell as the Industry Faces Legal Uncertainty in 2024

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that its brand, Spinach®, closed 2023 as the number one ranked flower brand in Canada with a 6.9%1 market share in the fourth quarter. Spinach® flower products have resonated strongly with consumers, leading to a significant increase in its ranking from the fourth2 best-selling flower brand in 2022, to become the best-selling flower brand in Canada in 2023.

Cronos' Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1

Scotts Miracle-Gro

With almost the first month of 2024 gone legal cannabis is put on the front lines once again. Over the next several months we will see more states try to not only pass legalization measures but improve upon existing laws. Although cannabis is still federally illegal more than half of the US has legalized cannabis in some form. Whether it is a recreational market or a medical market being able to operate legally is a major win. Yet it is only one of the many pieces to the framework of legal cannabis.

This Is Why Marijuana Stocks Recover From New Cannabis Laws

Hive Blockchain Technologies Ltd

IAMGOLD

The fear of missing out generally results in losses as investors enter a stock at peak euphoria. The same story would have been ignored at cheap valuations.

3 Overlooked Small-Cap Stocks Poised to Skyrocket Soon

Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-related stocks. This includes companies involved in cultivation, production, and retail. The U.S. cannabis industry has seen remarkable growth. Statistics reveal a projected market size of over $30 billion by 2025. This growth is fueled by expanding legalization and increased consumer acceptance. Investors are increasingly attracted to this sector for its high-growth potential. However, the industry faces regulatory challenges and market volatility.

Cultivating Wealth: 2024's Top Cannabis ETFs for Long Term Investors

As we delve into Q1 2024, the Canadian cannabis market and its top marijuana stocks continue to captivate investors' attention. This sector, a trailblazer due to Canada's early legalization, is buzzing with companies showing adaptability and innovation. They are swiftly responding to evolving regulations and consumer preferences, fueling investor interest. The backdrop to this is the burgeoning global cannabis industry, projected to skyrocket in the upcoming years. Analysts predict a compound annual growth rate (CAGR) of around 28% from 2021 to 2028. This growth is propelled by wider legalization and an expanding array of cannabis-infused products.

Navigating Canadian Cannabis: Top Stocks for Q1 2024

The last decade saw a trend for destigmatization of the use of psychoactive substances accompanied by a wave of legislation either legalizing or decriminalizing mostly marijuana-based products – both for medical and recreational use.

Marijuana stocks to watch in 2024

High Tide

This week, investors are turning their eyes to marijuana stocks and the Canadian cannabis sector, a rapidly growing area in the global market. As the industry evolves, Canadian stocks are emerging as key players to watch. The global cannabis market, already worth billions, is projected to expand significantly. This growth is spurred by the increasing legalization and acceptance of cannabis for both medical and recreational use. For those looking to invest, the potential for high returns from top Canadian cannabis stocks is an exciting prospect.

Canadian Cannabis Stocks to Keep an Eye On in Early 2024

Polestar Automotive Holding UK PLC

Penny stocks can be portfolio game changers even with a 10% to 15% allocation. The reason is that 5x or 10x returns in relatively quick time is not an unrealistic expectation.

Tiny Tickers, Tons of Potential: 3 Penny Stocks Set to Soar

TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution into the Australian market with its first shipment of cannabis flower to Vitura Health Limited (“Vitura”) (ASX: VIT). Cronos owns approximately 10% of the common shares of Vitura, formerly known as Cronos Australia, and will supply cannabis for Vitura.

Cronos Enters Australian Cannabis Market

There finally seems to be light at the end of the tunnel for the cannabis industry. It's difficult to talk about the regulatory perspective.

The 3 Hottest Cannabis Stocks to Watch in 2024

Cannabis stocks are notching their second day of gains after the Drug Enforcement Administration confirmed it's reviewing an August recommendation from the U.S. Department of Health and Human Services (HHS) to change the classification of marijuana to Schedule III from Schedule I under the Controlled Substances Act. In a letter to Rep.

Cannabis stocks mark second day of gains as DEA confirms its review of marijuana's Schedule I classification

Trading penny stocks can deliver robust returns in the blink of an eye. In the last month, Tilray Brands(NASDAQ: TLRY ) stock has surged by roughly 30%.

Low-Cost, High-Potential: 3 Stocks Under $5 with Surprising Upside

Village Farms International

Marijuana stock investors have been through a lot of obstacles these last few years. In 2022 the sector was just coming out of the pandemic and 2023 has been about rebuilding the sector. Still even with continued success there was increased volatile trading. Much of this volatile action is based on fears and hold-ups on regulatory concerns. For instance, there are some who fear an industry shut down due to a lack of reform. Also, cannabis is still federally illegal which has been the biggest cause of this volatility.

Cannabis Investors Are Focused On Top Canadian Marijuana Stocks

During the same time last year, Riot Platforms (NASDAQ: RIOT ) stock was trading close to $3. As Bitcoin ( BTC-USD ) surged higher, RIOT stock has skyrocketed to $17.8.

3 Stocks Under $3 That Can Trade in Double Digits by 2025

TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is proud to announce the launch of its highly anticipated Lord Jones® Live Resin Vapes in two different hardware options. Crafted with the discerning cannabis consumer in mind, these products embody a commitment to excellence, offering an unmatched combination of curated strains, pure live resin, and elegant high-quality hardware.

Premium Cannabis Brand Lord Jones® Launches Live Resin Vapes

Innovative Industrial Properties

In the bustling stock markets, the cannabis industry has emerged as a dynamic arena, captivating investors with its promise of rapid evolution and immense growth potential. As the smoke clears from regulatory shifts and market fluctuations, the spotlight shines on three trailblazing cannabis stocks poised for substantial strides in 2024.

Budding Potential: 3 Cannabis Stocks Poised for Growth in 2024

The Canadian cannabis industry and top Canadian marijuana stocks are poised for significant growth as we approach 2024. With Canada being one of the first major economies to legalize cannabis for both medical and recreational use, the sector has seen substantial development. This pioneering step has paved the way for a burgeoning market. Companies in this space are experiencing rapid expansion. Investors are keenly watching Canadian cannabis stocks. These stocks are seen as promising investment opportunities.

2024 Watchlist: Top Canadian Cannabis Stocks on the Rise

Without a doubt, the best time to buy stocks in a sector is when sentiments are significantly bearish. Or as the saying goes: “buy when there is fear in the streets and sell when there is greed.

News for Cronos Group Stock (CRON)